1943: Interview with CEO Martin Gouldstone of Oncimmune

episode

The Vox Markets Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Layoffs at the Kansas City Star will hurt local communities 15 min · 18 Sep 2026 · Kansas City Today

A Brutally Honest Review of Practical Magic 2 56 min · 18 Sep 2026 · The Spill

NPR News: 09-18-2026 1AM EDT 4 min · 18 Sep 2026 · NPR News Now

1AM ET 09/18/2026 Newscast 3 min · 18 Sep 2026 · Fox News Hourly Update

The Power of the Spirit in Preaching 6 min · 18 Sep 2026 · Things Unseen with Sinclair B. Ferguson

Report any issue

Source

Recorded09 Sep 2024

Publisheraudioboom.com ↗

Handlerec:10923235

Show notes

In this upbeat interview, CEO Martin Gouldstone of Oncimmune - a leading life sciences firm providing autoantibody profiling services that are used to enable precision medicine within the Biopharma industry – takes me through today’s positive yearend trading update, 3 contract wins and exciting road ahead.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in